- Home
- Research
- Mental Health
- Examining the chronicity of suicidal thoughts and behaviors among Australian males.
Suicidal thoughts persist in over one-third of at-risk Australian men
Examining the chronicity of suicidal thoughts and behaviors among Australian males.
AI Summary
This Australian study examined the long-term persistence of suicidal thoughts and behaviors (STB) among 3,070 males over a nine-year period. The research found that more than one in three men who reported lifetime suicidal thoughts experienced chronic STB, with 34.5% reporting persistent suicidal thoughts and 13.6% experiencing recurring suicide attempts. The study used data from the Ten to Men cohort study and employed advanced statistical modeling to identify factors predicting chronic suicidal ideation.
The research identified several critical risk factors associated with persistent suicidal thoughts and behaviors. Depression emerged as the strongest predictor, with those experiencing depression being 2.57 times more likely to develop chronic STB over the nine-year period. Alcohol use disorder and marijuana use were also significant predictors, with marijuana use increasing the risk by 33%. Additional factors included disability and socioeconomic disadvantages, painting a complex picture of interconnected mental health and substance use challenges among Australian men.
The findings highlight the need for targeted intervention strategies addressing the root causes of chronic suicidal ideation, particularly focusing on depression treatment, substance use support, and socioeconomic support. For individuals concerned about mental health or substance use patterns, this research underscores the importance of comprehensive mental health assessment and early intervention, rather than addressing these issues in isolation.
📄
Original Abstract
Related Research
Similar Studies
More Mental Health research papers you might find interesting.
Review describes AHC and reports cannabidiol as an additional treatment option
Review finds school prevention often covers cannabis, but evidence gaps remain
Antipsychotics eased symptoms, but relapse-prevention evidence remains thin
Explore More Research
Stay informed about the latest cannabis science.